Critical Considerations of mRNA-LNPs Technology for CAR-T Therapy: Components, Payloads and Emerging Horizons

Chimeric Antigen Receptor T (CAR-T) therapy has shown great success in treating hematologic tumors. However, current methods of producing CAR-T cells in vitro and in vivo have drawbacks in terms...